ROLE OF C-KIT IN EARLY HEMATOPOISESIS
C-KIT 在早期造血中的作用
基本信息
- 批准号:3087834
- 负责人:
- 金额:$ 7.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-07-01 至 1996-06-30
- 项目状态:已结题
- 来源:
- 关键词:anemia bone marrow exam cytokine dyserythropoietic anemia erythroleukemia flow cytometry gene expression genetic promoter element growth factor receptors hematopoiesis hematopoietic growth factor hematopoietic stem cells human fetus tissue human subject human tissue immunoprecipitation leukemia luciferin monooxygenase monoclonal antibody polymerase chain reaction protein tyrosine kinase protooncogene radioimmunoassay receptor expression reporter genes tissue /cell culture western blottings
项目摘要
Hematopoiesis is the process by which hematopoietic precursor cells undergo
self-renewal and differentiation into the various mature blood cell
lineages. Growth factor-receptor interactions play a significant role in
the regulation of normal hematopoiesis, affecting both proliferation and
differentiation of various hematopoietic lineages. Alterations of these
receptors plays an important role in myelodysplasia and leukemogenesis.
The kit proto-oncogene encodes for a tyrosine-kinase transmembrane receptor
that is expressed on very early hematopoietic precursor cells, and is
involved in stem cell migration and differentiation. The growth factor
ligand for the kit receptor, known as stem cell factor, has been recently
purified. The purpose of our study is to investigate the role of growth
factor-receptor interactions on the regulations of hematopoiesis. We will
investigate the role of the kit receptor in hematopoiesis by studying its
expression and tyrosine kinase activity in both cultured cell lines and in
hematopoietic cells isolated from bone marrow samples from human subjects.
Expression of the kit receptor will be easily monitored using a monoclonal
antibody which we have developed. The effects of various cytokines,
including stem cell factor, on cells that express the kit receptor will be
studied. Finally we will look for abnormal kit expression and/or function
in patients with hematological disorders including leukemias,
myelodysplastic disorders, and congenital anemias. Those patients whose
cells show abnormal kit expression or function will be further investigated
to define the defect at the molecular level. These studies should enhance
our knowledge of the role of growth factor-receptor interactions in normal
and abnormal states o hematopoiesis, thus leading to a better understanding
of the pathophysiology of certain hematological diseases, and possibly lead
to better therapies for these diseases.
造血是造血前体细胞经历的过程
自我更新和分化成各种成熟的血细胞
血统 生长因子-受体相互作用在
正常造血的调节,影响增殖和
各种造血谱系的分化。 修改这些
受体在骨髓增生异常和白血病发生中起重要作用。
kit原癌基因编码酪氨酸激酶跨膜受体
它在非常早期的造血前体细胞上表达,并且
参与干细胞迁移和分化。 所述生长因子
kit受体的配体,称为干细胞因子,最近已被
提纯 我们研究的目的是调查增长的作用
因子-受体相互作用对造血调控的影响。 我们将
研究kit受体在造血中的作用,
表达和酪氨酸激酶活性,
从人类受试者的骨髓样本中分离的造血细胞。
试剂盒受体的表达将使用单克隆抗体容易地监测。
我们开发的抗体。 各种细胞因子的作用,
包括干细胞因子,对表达kit受体的细胞的作用,
研究了 最后,我们将寻找异常试剂盒表达和/或功能
在患有包括白血病的血液疾病的患者中,
骨髓增生异常疾病和先天性贫血。 的那些患者
将进一步研究显示异常kit表达或功能的细胞
在分子水平上定义缺陷。 这些研究应加强
我们对生长因子-受体相互作用在正常发育过程中的作用的认识,
和异常状态的造血,从而导致更好地了解
某些血液病的病理生理学,并可能导致
更好的治疗方法
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carlos M. De Castro其他文献
CT-118: PH3 Study of Efficacy and Safety of Iptacopan (LNP023), an Oral Complement Factor B Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia Despite Anti-C5 Antibody Treatment
- DOI:
10.1016/s2152-2650(21)01998-4 - 发表时间:
2021-09-01 - 期刊:
- 影响因子:3.2
- 作者:
Antonio M. Risitano;Austin Kulasekararaj;Carlos M. De Castro;Phillip Scheinberg;Rafael Levitch;Georgina Bermann;Marion Dahlke;Régis Peffault de Latour - 通讯作者:
Régis Peffault de Latour
Poster: CT-118: PH3 Study of Efficacy and Safety of Iptacopan (LNP023), an Oral Complement Factor B Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia Despite Anti-C5 Antibody Treatment
- DOI:
10.1016/s2152-2650(21)01635-9 - 发表时间:
2021-09-01 - 期刊:
- 影响因子:
- 作者:
Antonio M. Risitano;Austin Kulasekararaj;Carlos M. De Castro;Phillip Scheinberg;Rafael Levitch;Georgina Bermann;Marion Dahlke;Régis Peffault De Latour - 通讯作者:
Régis Peffault De Latour
Carlos M. De Castro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}